Xarelto is a brand-name oral anticoagulant that contains the active ingredient rivaroxaban. It belongs to the class of direct Factor Xa inhibitors and is used to reduce the risk of blood clots in various cardiovascular conditions. Xarelto is supplied as a pill in three strengths - 10 mg, 15 mg, and 20 mg - and is available by prescription only in Hong Kong. The drug is regulated by the Hong Kong Department of Health and has also received approval from major agencies such as the U.S. FDA and the European EMA.
Rivaroxaban directly blocks Factor Xa, a key enzyme in the coagulation cascade that converts prothrombin to thrombin. By inhibiting this step, the drug reduces the generation of fibrin, the protein mesh that forms a blood clot.
Because rivaroxaban is taken orally and is rapidly absorbed, it does not require the frequent laboratory monitoring that older anticoagulants (e.g., warfarin) need.
Xarelto is approved in Hong Kong for the following indications, all of which involve prevention or treatment of thromboembolic events:
The medication is prescribed for adults; dosing varies according to the specific condition and individual patient factors such as kidney function.
Research and clinical guidelines have explored additional scenarios where rivaroxaban may be beneficial, although these uses are not approved by Hong Kong regulatory agencies:
Disclaimer: Off-label use requires close medical supervision, a thorough risk-benefit assessment, and adherence to local clinical guidelines.
Patients with any of the above conditions should discuss alternatives or dose modifications with their healthcare provider.
These events are typically reported in more than 1 % of users but seldom require discontinuation.
If any severe bleeding occurs, seek emergency care immediately.
Patients should provide a complete medication list, including over-the-counter products and herbal supplements, to their prescriber before starting Xarelto.
All doses refer to the available tablet strengths (10 mg, 15 mg, 20 mg).
If a dose is missed and the scheduled dosing time is still more than 12 hours away, take the missed dose as soon as remembered and then continue with the regular schedule. Do not double the dose.
Signs may include severe or uncontrolled bleeding, dizziness, or fainting. Immediate medical attention is required. Activated charcoal may be considered if ingestion was recent; there is no specific antidote approved in Hong Kong, though andexanet alfa is available in some regions for emergency reversal.
Do not stop Xarelto abruptly without consulting a healthcare professional, especially if it is being used for stroke prevention in atrial fibrillation. In most cases, a bridging strategy with a short-acting anticoagulant is not required, but individual assessment is essential.
Routine laboratory monitoring of coagulation (e.g., INR) is not required with rivaroxaban. However, the following assessments are recommended:
Patients should seek prompt medical review if they experience unexplained bruising, prolonged bleeding from cuts, or signs of anemia (fatigue, shortness of breath).
This article provides educational information about Xarelto and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
Yes, Xarelto can be carried in hand luggage, but you should keep the original prescription label and a copy of the prescription to satisfy customs or airport security checks. In some jurisdictions, a doctor’s letter may be required for extended supplies.
Xarelto tablets are round, white to off-white, and bear the imprint “RIV 20,” “RIV 15,” or “RIV 10” corresponding to the 20 mg, 15 mg, and 10 mg strengths. The imprint helps distinguish them from other oral medications.
Standard employment drug screens do not test for anticoagulants. However, if a specific assay is ordered (e.g., for a medical investigation), rivaroxaban can be measured using specialized laboratory techniques.
Both drugs lower stroke risk in atrial fibrillation, but Xarelto does not require routine INR monitoring, has fewer food and drug interactions, and provides a more predictable anticoagulant effect. Warfarin remains useful for patients with mechanical heart valves, where Xarelto is contraindicated.
If it is less than 12 hours until the next scheduled dose, take the missed tablet as soon as you remember and then continue with the regular timing. Do not take two tablets at once.
No major dietary restrictions exist. However, for the 15 mg and 20 mg doses, taking the tablet with a meal that contains some fat enhances absorption, so it is advisable to eat food at the time of dosing.
Xarelto is not recommended for patients on dialysis because the drug’s clearance is significantly reduced, raising the risk of bleeding. Alternative anticoagulants should be considered.
Generic rivaroxaban, when available, is generally less expensive than the branded product due to reduced manufacturing and marketing costs. Exact pricing varies by pharmacy and insurance coverage; patients should inquire locally for current rates.
Early observational studies suggested potential benefits of anticoagulation in severe COVID-19, but definitive randomized trials are limited. Current guidelines recommend using prophylactic-dose anticoagulants as indicated, and Xarelto may be considered when oral therapy is appropriate and no contraindications exist.
The tablet’s stability is ensured as long as it remains in the original, tightly sealed container and is stored at room temperature. The expiration date printed on the bottle reflects the product’s shelf life, regardless of when the bottle is first opened.
